Project Grant R21AI185883
Award Date
1/28/25
Completion Date
12/31/26
Dollars Obligated
$193K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Davis, CA, USA
Similar Awards
This $2,074,701 federal Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The project aims to advance understanding of the biological and physical drivers of influenza A virus (IAV) transmission in humans. Key objectives include: Defining the dynamics of viral load, immune responses, and infectious aerosol production in humans infected with seasonal IAV using a controlled...
This Project Grant award, valued at $792,687.00 and issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to define the structural features of sialoglycans necessary for influenza A virus (IAV) infection and adaptation across various host species. The key activities under this award include: 1) using CRISPR/Cas9 techniques to truncate different types of sialoglycans in human lung...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to elucidate the mechanisms by which influenza co-infection can protect against malaria-associated respiratory distress syndrome (MA-ARDS) in mice. The $224,070 award, effective from February 2025 through March 2027, will enable the University of Utah to investigate how influenza modifies pulmonary...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $146,922 to Emory University to conduct research on factors that influence the efficiency of influenza A virus (IAV) infection through different modes of exposure. The project aims to examine the relationship between the intensity of IAV exposure (via intranasal inoculation or aerosol) and the diversity of...
This $239,120 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research by Tufts University School of Medicine to analyze the heterogeneity of cell death responses in influenza virus-infected cells. The goal is to better understand the complex interplay between influenza viral infection, cell death pathways, and the host immune response, with the aim of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $785,511 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Chicago. The purpose of this 5-year project, which commenced on January 24, 2025, is to leverage induced pluripotent stem cell-derived macrophages to: Characterize inter-individual and inter-population variability in immune responses to Mycobacterium tuberculosis and influenza virus infections in humans....
This federal Project Grant award of $451,292.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to uncover neuronal mechanisms that orchestrate metabolic adaptations to bacterial infections, with a focus on delineating the role of the brain-liver axis in modulating metabolic responses. The research seeks to identify neurocircuits in the hypothalamus that monitor circulating lipoproteins and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $269,054 to the University of California, Merced to conduct research on mechanisms of resistance to Toxoplasma gondii infection in mice. The research aims to leverage the Collaborative Cross mouse panel and parasite genetics to identify novel host susceptibility genes and host-parasite interactions that...
This $249,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is funding research to elucidate the mechanisms underlying hepatitis delta virus (HDV) pathogenesis. The key objectives are to determine the proviral role of the MDA5 signaling pathway in HDV infection and define the mechanism of HDV-induced hepatocyte-intrinsic programmed cell death. The research aims to provide novel...
The University of California, Davis was awarded a $811,009 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant will support the development and validation of a novel microfluidic device called the "Shear-Force Avidity-based Cell Selector (SACS)" to rapidly assess the functional immunity of memory B cells against influenza infection. The project aims to: 1) enhance the...